topical therapy

ASHBURN, Va. — September 22, 2026 Quoin Pharmaceuticals announced that the U.S. Food and Drug Administration has granted Fast...

BALLERUP, Denmark — September 18, 2026 LEO Pharma announced that the European Medicines Agency’s Committee for Medicinal Products for...

Westlake Village, California, August 20, 2026 Turn Therapeutics announced new peer-reviewed research providing in-vivo evidence that GX-03 selectively reduces...

BALLERUP, Denmark, April 17, 2026 LEO Pharma A/S has secured a major regulatory milestone with the approval of Enstilar®...